Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Cardiogenic shock; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority-WEB FR-AFSSAPS-2021069082. A 73-year-old male patient received bnt162b2 (COMIRNATY, Lot Number: EW2239), second dose intramuscular on 23Apr2021 as 2nd dose, single for covid-19 immunization. Medical history included asthma, hypertension arterial, pulmonary embolism, dementia, type 2 diabetes mellitus all from an unknown date and unknown if ongoing. The patient''s concomitant medications were not reported. The patient experienced cardiogenic shock on 06May2021. Cardiogenic shock on day 14 of second dose pending hospitalization CR (serum creatinine), it will be the subject of a new version. The outcome of event was fatal. The patient died on 06May2021. An autopsy was not performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Arrest cardiac
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166